SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-25-001779
Filing Date
2025-01-10
Accepted
2025-01-10 17:11:35
Documents
42
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 663019
2 ex31-1.htm EX-31.1 17101
3 ex31-2.htm EX-31.2 17088
4 ex32-1.htm EX-32.1 8167
  Complete submission text file 0001493152-25-001779.txt   3508373

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE vicp-20240930.xsd EX-101.SCH 25330
6 XBRL CALCULATION FILE vicp-20240930_cal.xml EX-101.CAL 29747
7 XBRL DEFINITION FILE vicp-20240930_def.xml EX-101.DEF 121800
8 XBRL LABEL FILE vicp-20240930_lab.xml EX-101.LAB 228486
9 XBRL PRESENTATION FILE vicp-20240930_pre.xml EX-101.PRE 178998
44 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 459274
Mailing Address 1735 BUFORD HIGHWAY STE. 215-113 CUMMING GA 30041
Business Address 1735 BUFORD HIGHWAY STE. 215-113 CUMMING GA 30041 470-514-4013
Vicapsys Life Sciences, Inc. (Filer) CIK: 0001468639 (see all company filings)

IRS No.: 621153426 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56145 | Film No.: 25523887
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)